Presentations

Hans Bijlsma, Professor of Rheumatology, University Medical Center Utrecht, The Netherlands
Is there a safe way to use glucocorticoids?

Dimitrios T. Boumpas, MD, FACP Professor of Medicine and Head, Department of Medicine, University of Crete, Greece
Treatment challenges

Bernard Combe, Professor of Rheumatology, Rheumatology Department, Lapeyronie Hospital, Montpellier 1 University, Montpellier, France
Remission is a realistic goal in RA: YES

Juliet Compston, Professor of Bone Medicine and Honorary Consultant Physician, Division of Bone Research, Department of Medicine, University of Cambridge, UK
Steroid-induced osteoporosis: assessing risk

Betty Diamond, Investigator/ Head, Center of Autoimmune and Musculoskeletal Disease, The Feinstein Institute for Medical Research, USA
Systemic autoimmunity

Richard Furie, MD, Chief, Division of Rheumatology and Allergy, Clinical Immunology, North Shore, Long Island Jewish Health System, USA
Trials of biologics in SLE

Cem Gabay, Professor of Medicine, Head of the Division of Rheumatology, University Hospitals of Geneva, Switzerland
Rituximab dosing: on demand or fixed?

Walter Grassi, Professor of Rheumatology, Clinica Reumatologica, Università Politecnica delle Marche, Ancona, Italy
Image analysis in ultrasound

Ahmet Gul, Professor of Medicine, Division of Rheumatology, Department of Internal Medicine, Istanbul Faculty of Medicine, Istanbul University, Turkey
Genetics of autoinflammation (including Behcet’s) (18/2

Garry S. Hoffman, Harold C. Schott Professor of Medicine, Cleveland Clinic Foundation/Lerner College of Medicine, USA
New concepts in angiitis

Jonathan Kay, M.D., Director of Clinical Research, Division of Rheumatology, Professor of Medicine, University of Massachusetts Medical School, UMass Memorial Medical Center, Worcester, MA, USA
Clinical assessment of disease activity

Clive Kelly, Consultant Physician, Queen Elizabeth Hospital, Gateshead, UK
Interestial lung disease

George D. Kitas, Professor, Consultant Rheumatologist, Director of Research & Development, Clinical Director, Ambulatory Care, Dudley Group of Hospitals, UK
A common sense approach to the assessment and management of CVD in RA

Ayse A. Kucukdeveci, Professor, Department of Physical Medicine and Rehabilitation, Medical Faculty of Ankara University, Turkey
Functional assessment in arthritis: current practice and future directions

Tore K. Kvien, Professor, University of Oslo & Head of Department, Department of Rheumatology, Diakonhjemmet Hospital, Norway
Remission is a realistic goal in RA: NO

Robert Lahita, Chairman of Medicine, Newark Beth Israel Medical Center, USA
Latest developments in lupus therapeutics

Robert Lafyatis, Professor of Medicine, Boston University Medical Center, USA
Systemic sclerosis distinguishing what is from, what could be: biomarkers of disease activity

Marjatta Leirisalo-Repo, Professor, Helsinki University Central Hospital and Helsinki University, Finland
Should we always use combination treatment in patients with RA?

Raashid Luqmani, Consultant Rheumatologist/Senior Lecturer, Rheumatology Department, Nuffield Orthopaedic Centre and University of Oxford, UK
Long-term outcomes in small-vessel vasculitis, including malignancy

Susan Manzi, Chair, Department of Medicine, West Penn Allegheny Health System, USA
Mechanisms of CVD morbidity/mortality in SLE: classical CVD risk vs SLE specific factors

Charles Masson, MD, Service de Rhumatologie, CHU Angers, France
Anaemia of chronic disease

Monica Ostensen, Consultant, Pregnancy Research Unit, Department of Rheumatology, University of Bern, Switzerland
The management of pregnancy in RA

Theodore Pincus, Clinical Professor of Medicine, New York University School of Medicine and NYU Hospital for Joint Diseases, USA
Validity of patient self-report questionnaires: content validity, prognostic validity, and diagnostic validity

Janet Pope, MD FRCPC MPH, Professor of Medicine and Division Head, Rheumatology, University of Western Ontario, Schulich School of Medicine & Dentistry, St. Joseph’s Health Care, London, Ontario, Canada
How to apply tight control in daily practice

John Scott, Professor, Consultant in Pulmonary Medicine and Medical Director Lung Transplant Program Mayo Clinic, Mayo Clinic School of Medicine, Mayo Clinic and Mayo Foundation, USA
Lung transplant in CTD

Yehuda Shoenfeld, Professor, Head of Center for Autoimmunity, Department of Medicine ‘B’, Sheba Medical Center (Affiliated to Tel-Aviv University), Israel
APLS is a separate entity or a brother of SLE?
Asia and new syndrome of adjuvant induced autoimmunity

John Stone, Clinical Director, Rheumatology Unit, Massachusetts General Hospital, USA
CNS Vasculitis
The syndrome of central nervous system “vasculitis” – clinical progress despite many unknows

Gregory Summers, Consultant Rheumatologist, Royal Derby Hospital, UK
Rheumatoid cachexia

Peter C. Taylor, Professor, Head of Clinical Trials and Campus Dean, Kennedy Institute of Rheumatology Division, Imperial College London, UK
After failure of anti-TNF: what to do?
Neutropaenia with biologics

George C. Tsokos, Professor, Chief, Rheumatology Division, Beth Israel Deaconess Medical Center, Harvard Medical School, USA
Mining the biochemistry of the immune cell for the development of novel targets and biomarkers

Piet van Riel, Professor, Head of the Department of Rheumatology, University Medical Centre Nijmegen, The Netherlands
The assessment of (rheumatoid) arthritis in clinical trials and daily practice
Clinical assessment of disease activity

Martinus A.F.J. van de Laar, Professor Dr., Rheumatologist, Medisch Spectrum Twente & University Twente, The Netherlands
Treat to target or target to treat? Is personalized medicine already feasible?

John Varga, John and Nancy Hughes Distinguished Professor in Rheumatology, Northwestern University in Chicago, USA
Novel concepts in the pathogenesis of scleroderma

Dimitrios Vassilopoulos, MD, Associate Professor of Medicine-Rheumatology, Athens University School of Medicine, Greece
Hepatitis and anti-TNFs: do’s and don’t’s

Bruce Volpe, Professor of Neurology & Neuroscience, Weill Medical College, Cornell University, USA
Mechanisms of brain injury
CNS disease in systemic autoimmunity